MYO / Myomo, Inc.'s (MYO) CEO Paul Gudonis on Q2 2022 Results - Earnings Call Transcript

Myomo (NYSEMKT: MYO ) stock is dropping on Monday after the wearable medical robotics company priced a public share offering. A press release from My more_horizontal

Myomo, Inc. (MYO) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.42 per shar more_horizontal

Myomo, Inc. (NYSE:MYO ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Kim Golodetz - Investor Relations, LHA Paul Gu more_horizontal

If this rule is finalized without any changes to reimbursement practices, Myomo's (MYO) MyoPro could be reimbursed in a lump-sum manner by CMS. more_horizontal

Myomo, Inc. (MYO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this t more_horizontal

Myomo, Inc. (MYO) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $ more_horizontal

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 34.09% and 0.45%, respectively, for the quarter ended December 2022. Do the numbers hold more_horizontal

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increase more_horizontal